May 2022 Publications
- A century of attempts to develop an effective tuberculosis vaccine: Why they failed? Soleimanpour S, Yaghoubi A, Sadat Seddighinia F, Rezaee SAR. Int Immunopharmacol. 2022 Apr 26. doi: 10.1016/j.intimp.2022.108791. Online ahead of print.
- Replication and transmission features of two experimental vaccine candidates against bovine tuberculosis subcutaneously administrated in a murine model. Muñiz XF, García EA, Blanco FC, Bigi F, Zumárraga MJ, Cataldi AA, Eirin ME. Tuberculosis (Edinb). 2022 May. doi: 10.1016/j.tube.2022.102203. Epub 2022 Mar 29.
- Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster. Mao L, Xu L, Wang X, Xing Y, Wang J, Zhang Y, Yuan W, Du J, Shi Z, Ma J, Zhang J, Zhang X, Wang X. Tuberculosis (Edinb). 2022 May. doi: 10.1016/j.tube.2022.102186. Epub 2022 Feb 26.
- Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition. Bender Ignacio RA, Long J, Saha A, Nguyen FK, Joudeh L, Valinetz E, Mendelsohn SC, Scriba TJ, Hatherill M, Janes H, Churchyard G, Buchbinder S, Duerr A, Shah JA, Hawn TR. PLoS One. 2022 May 3. doi: 10.1371/journal.pone.0267729. eCollection 2022.
- Innovative vaccine approaches-a Keystone Symposia report. Cable J, Rappuoli R, Klemm EJ, Kang G, Mutreja A, Wright GJ, Pizza M, Castro SA, Hoffmann JP, Alter G, Carfi A, Pollard AJ, Krammer F, Gupta RK, Wagner CE, Machado V, Modjarrad K, Corey L, B Gilbert P, Dougan G, Lurie N, Bjorkman PJ, Chiu C, Nemes E, Gordon SB, Steer AC, Rudel T, Blish CA, Sandberg JT, Brennan K, Klugman KP, Stuart LM, Madhi SA, Karp CL. Ann N Y Acad Sci. 2022 May. doi: 10.1111/nyas.14739. Epub 2022 Jan 14.
- Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro. Diray-Arce J, Angelidou A, Jensen KJ, Conti MG, Kelly RS, Pettengill MA, Liu M, van Haren SD, McCulloch SD, Michelloti G, Idoko O; EPIC Consortium, Kollmann TR, Kampmann B, Steen H, Ozonoff A, Lasky-Su J, Benn CS, Levy O. Cell Rep. 2022 May 3. doi: 10.1016/j.celrep.2022.110772.
- Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17. Moodley A, Fatoba A, Okpeku M, Emmanuel Chiliza T, Blessing Cedric Simelane M, Pooe OJ. Immunol Res. 2022 May 12. doi: 10.1007/s12026-022-09284-x. Online ahead of print.
- Therapeutic Effect of Subunit Vaccine AEC/BC02 on Mycobacterium tuberculosis Post-Chemotherapy Relapse Using a Latent Infection Murine Model. Lu J, Guo X, Wang C, Du W, Shen X, Su C, Wu Y, Xu M. Vaccines (Basel). 2022 May 23. doi: 10.3390/vaccines10050825.
- Recombinant BCG to Enhance Its Immunomodulatory Activities. Kowalewicz-Kulbat M, Locht C. Vaccines (Basel). 2022 May 23. doi: 10.3390/vaccines10050827.
- Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives. Dellagostin OA, Borsuk S, Oliveira TL, Seixas FK. Vaccines (Basel). 2022 May 19. doi: 10.3390/vaccines10050802.
- Vaccination of Holstein heifers with Mycobacterium bovis BCG strain induces protection against bovine tuberculosis and higher milk production yields in a natural transmission setting. Retamal P, Ábalos P, Alegría-Morán R, Valdivieso N, Vordermeier M, Jones G, Saadi K, Perez Watt C, Salinas C, Ávila C, Padilla V, Benavides B, Orellana R. Transbound Emerg Dis. 2022 May. doi: 10.1111/tbed.14108. Epub 2021 May 22.
- Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?. Dockrell HM, McShane H. EBioMedicine. 2022 May. doi: 10.1016/j.ebiom.2022.103993. Epub 2022 Apr 12.
- Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays. Dirix V, Dauby N, Hites M, Watelet E, Van Praet A, Godefroid A, Petit E, Singh M, Locht C, Mascart F, Corbière V. J Clin Microbiol. 2022 May 18. doi: 10.1128/jcm.02443-21. Epub 2022 Apr 18.
- [Progress of regulatory T cells in the regulation of anti-tuberculosis immunity]. Li HR, Yao C, Li SS, Wang W, Pang Y. Zhonghua Jie He He Hu Xi Za Zhi. 2022 May 12. doi: 10.3760/cma.j.cn112147-20210830-00609.
- Antigen presentation by MHC-E: a putative target for vaccination?. Voogd L, Ruibal P, Ottenhoff THM, Joosten SA. Trends Immunol. 2022 May. doi: 10.1016/j.it.2022.03.002. Epub 2022 Mar 31.
- Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. Gideon HP, Hughes TK, Tzouanas CN, Wadsworth MH 2nd, Tu AA, Gierahn TM, Peters JM, Hopkins FF, Wei JR, Kummerlowe C, Grant NL, Nargan K, Phuah JY, Borish HJ, Maiello P, White AG, Winchell CG, Nyquist SK, Ganchua SKC, Myers A, Patel KV, Ameel CL, Cochran CT, Ibrahim S, Tomko JA, Frye LJ, Rosenberg JM, Shih A, Chao M, Klein E, Scanga CA, Ordovas-Montanes J, Berger B, Mattila JT, Madansein R, Love JC, Lin PL, Leslie A, Behar SM, Bryson B, Flynn JL, Fortune SM, Shalek AK. Immunity. 2022 May 10. doi: 10.1016/j.immuni.2022.04.004. Epub 2022 Apr 27.
- BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus. Soto JA, Díaz FE, Retamal-Díaz A, Gálvez NMS, Melo-González F, Piña-Iturbe A, Ramírez MA, Bohmwald K, González PA, Bueno SM, Kalergis AM. Vaccines (Basel). 2022 May 4. doi: 10.3390/vaccines10050721.
- Mycobacterium tuberculosis impedes CD40-dependent notch signaling to restrict Th(17) polarization during infection. Enriquez AB, Sia JK, Dkhar HK, Goh SL, Quezada M, Stallings KL, Rengarajan J. iScience. 2022 Apr 26. doi: 10.1016/j.isci.2022.104305. eCollection 2022 May 20.
- Mycobacterium tuberculosis antigen-specific T cell responses in smear- negative pulmonary tuberculosis patients. Esmael A, Abebe T, Mihret A, Mussa D, Neway S, Ernst J, Rengarajan J, Wassie L, Howe R. Clin Exp Immunol. 2022 May 12:uxac049. doi: 10.1093/cei/uxac049. Online ahead of print.
- Ex vivo Platforms to Study the Primary and Recall Immune Responses to Intracellular Mycobacterial Pathogens and Peptide-Based Vaccines. Davis WC, Mahmoud AH, Abdellrazeq GS, Elnaggar MM, Dahl JL, Hulubei V, Fry LM. Front Vet Sci. 2022 May 3. doi: 10.3389/fvets.2022.878347. eCollection 2022.
- Human lymph node immune dynamics as driver of vaccine efficacy: an understudied aspect of immune responses. Moysi E, Paris RM, Le Grand R, Koup RA, Petrovas C. Expert Rev Vaccines. 2022 May. doi: 10.1080/14760584.2022.2045198. Epub 2022 Mar 9.
- Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial. Upton CM, van Wijk RC, Mockeliunas L, Simonsson USH, McHarry K, van den Hoogen G, Muller C, von Delft A, van der Westhuizen HM, van Crevel R, Walzl G, Baptista PM, Peter J, Diacon AH; BCG CORONA Consortium. EClinicalMedicine. 2022 Jun. doi: 10.1016/j.eclinm.2022.101414. Epub 2022 May 12.
- Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study. Wilkie M, Tanner R, Wright D, Lopez Ramon R, Beglov J, Riste M, Marshall JL, Harris SA, Bettencourt PJG, Hamidi A, van Diemen PM, Moss P, Satti I, Wyllie D, McShane H. Sci Rep. 2022 May 12. doi: 10.1038/s41598-022-11748-x.
- T cell transcription factor expression evolves over time in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques. Grant NL, Maiello P, Klein E, Lin PL, Borish HJ, Tomko J, Frye LJ, White AG, Kirschner DE, Mattila JT, Flynn JL. Cell Rep. 2022 May 17. doi: 10.1016/j.celrep.2022.110826.
- Correlation between innate and adaptive immunity response in TB children post BCG vaccination. Is it effective or not?: Cross-sectional study. Shabariah R, Farsida, Hatta M, Patellongi I, Idris I, Santoso A, Islam AA, Natzir R, Wahyudin B, Warsinggih, Sanjoyo. Ann Med Surg (Lond). 2022 Apr 6. doi: 10.1016/j.amsu.2022.103586. eCollection 2022 May.
- Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target “mtFabH” of Mycobacterium tuberculosis. Kumar N, Srivastava R, Mongre RK, Mishra CB, Kumar A, Khatoon R, Banerjee A, Ashraf-Uz-Zaman M, Singh H, Lynn AM, Lee MS, Prakash A. Front Microbiol. 2022 May 6. doi: 10.3389/fmicb.2022.818714. eCollection 2022.
- A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV. Warr AJ, Anterasian C, Shah JA, De Rosa SC, Nguyen FK, Maleche-Obimbo E, Cranmer LM, Matemo D, Mecha J, Kinuthia J, LaCourse SM, John-Stewart GC, Hawn TR. EBioMedicine. 2022 May 6. doi: 10.1016/j.ebiom.2022.104023. Online ahead of print.
- CD4 T cells are rapidly depleted from tuberculosis granulomas following acute SIV co-infection. Foreman TW, Nelson CE, Kauffman KD, Lora NE, Vinhaes CL, Dorosky DE, Sakai S, Gomez F, Fleegle JD, Parham M, Perera SR, Lindestam Arlehamn CS, Sette A; Tuberculosis Imaging Program, Brenchley JM, Queiroz ATL, Andrade BB, Kabat J, Via LE, Barber DL. Cell Rep. 2022 May 31. doi: 10.1016/j.celrep.2022.110896.
- Video Endoscopy-Guided Intrabronchial Spray Inoculation of Mycobacterium bovis in Goats and Comparative Assessment of Lung Lesions With Various Imaging Methods. Wedlich N, Figl J, Liebler-Tenorio EM, Köhler H, von Pückler K, Rissmann M, Petow S, Barth SA, Reinhold P, Ulrich R, Grode L, Kaufmann SHE, Menge C. Front Vet Sci. 2022 May 3. doi: 10.3389/fvets.2022.877322. eCollection 2022.